These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections. Musser JM Pediatr Ann; 1992 Dec; 21(12):821-2, 825-8. PubMed ID: 1480436 [No Abstract] [Full Text] [Related]
5. Streptococcal toxic shock syndrome due to noninvasive pharyngitis. Chapnick EK; Gradon JD; Lutwick LI; Kim J; Levi M; Kim MH; Schlievert PM Clin Infect Dis; 1992 May; 14(5):1074-7. PubMed ID: 1600009 [TBL] [Abstract][Full Text] [Related]
6. Streptococcal toxic shock-like syndrome. Clinical and microbiological aspects. Pugina P; Benzi G; Tini S; Cardinali A; Sbaraglia G Adv Exp Med Biol; 1997; 418():133-5. PubMed ID: 9331616 [No Abstract] [Full Text] [Related]
7. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates. Newton D; Norrby-Teglund A; McGeer A; Low DE; Schlievert PM; Kotb M Adv Exp Med Biol; 1997; 418():525-9. PubMed ID: 9331707 [No Abstract] [Full Text] [Related]
8. [The return of severe infections caused by Streptococcus pyogenes]. Verhoef-Verhage EA; van Houten A; Joore JC; Verbrugh HA Ned Tijdschr Geneeskd; 1993 Mar; 137(12):604-7. PubMed ID: 8459859 [TBL] [Abstract][Full Text] [Related]
9. Cases of streptococcal toxic shock syndrome in Germany since 1989, toxin (mitogen) expression, content of toxin genes and relation to M-serotypes. Günther E; Gerlach D; Reichardt W; Ozegowski JH; Zigann T Adv Exp Med Biol; 1997; 418():245-8. PubMed ID: 9331643 [No Abstract] [Full Text] [Related]
10. Streptococcal toxic shock syndrome from a puncture wound to the foot. Miller JH; Nath RL; Stoughton J; Carpenter BB; Mostone EJ J Foot Ankle Surg; 1996; 35(6):578-84. PubMed ID: 8986898 [TBL] [Abstract][Full Text] [Related]
11. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. Eriksson BK; Andersson J; Holm SE; Norgren M J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857 [TBL] [Abstract][Full Text] [Related]